These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16688772)

  • 1. T4 category revision enhances the accuracy and significance of stage III breast cancer.
    Güth U; Singer G; Langer I; Schötzau A; Herberich L; Holzgreve W; Wight E
    Cancer; 2006 Jun; 106(12):2569-75. PubMed ID: 16688772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification.
    Guth U; Wight E; Schotzau A; Langer I; Dieterich H; Rochlitz C; Herberich L; Holzgreve W; Singer G
    Cancer; 2005 Nov; 104(9):1862-70. PubMed ID: 16130140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach in breast cancer with non-inflammatory skin involvement.
    Güth U; Wight E; Schötzau A; Langer I; Dieterich H; Rochlitz C; Herberich L; Holzgreve W; Singer G
    Acta Oncol; 2006; 45(5):576-83. PubMed ID: 16864172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system.
    Harms K; Wittekind C
    Eur J Surg Oncol; 2009 Jan; 35(1):38-42. PubMed ID: 18215492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
    Duraker N; Caynak ZC
    Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T4 breast cancer under closer inspection: a case for revision of the TNM classification.
    Güth U; Jane Huang D; Holzgreve W; Wight E; Singer G
    Breast; 2007 Dec; 16(6):625-36. PubMed ID: 17604172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features.
    Gueth U; Wight E; Schoetzau A; Langer I; Dieterich H; Rochlitz C; Herberich L; Holzgreve W; Singer G
    J Surg Oncol; 2007 Mar; 95(4):291-7. PubMed ID: 17326124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninflammatory breast carcinoma with skin involvement.
    Güth U; Moch H; Herberich L; Holzgreve W
    Cancer; 2004 Feb; 100(3):470-8. PubMed ID: 14745862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer with non-inflammatory skin involvement: current data on an underreported entity and its problematic classification.
    Güth U; Huang DJ; Schötzau A; Dirnhofer S; Wight E; Singer G
    Breast; 2010 Feb; 19(1):59-64. PubMed ID: 20015652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups.
    Escobar PF; Patrick RJ; Rybicki LA; Weng DE; Crowe JP
    Ann Surg Oncol; 2007 Jan; 14(1):143-7. PubMed ID: 17058125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy.
    Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M
    Breast J; 2008; 14(3):245-9. PubMed ID: 18433402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
    Woodward WA; Strom EA; Tucker SL; McNeese MD; Perkins GH; Schechter NR; Singletary SE; Theriault RL; Hortobagyi GN; Hunt KK; Buchholz TA
    J Clin Oncol; 2003 Sep; 21(17):3244-8. PubMed ID: 12947058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
    Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
    Nassar A; Cohen C; Cotsonis G; Carlson G
    Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.